GlassScriptPhysician profile
Kunal Kumar
NPI 1437418068
$2,451.92
in general payments reported to CMS, 2019-2025
21 companies · $20.68 in 2025
The $20.68 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $207 · 2021: $173 · 2022: $205 · 2023: $559 · 2024: $138 · 2025: $20.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701 · Education: $16.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.18 |
| Education | $16.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $332.98 | 2019-2021 | |
| Harmony Biosciences LLC | $308.53 | 2023-2024 | Wakix |
| Genentech USA, INC. | $273.71 | 2019 | |
| Emd Serono, INC. | $267.14 | 2019-2020 | |
| Ucb, INC. | $240.14 | 2019 | |
| Jazz Pharmaceuticals INC. | $234.15 | 2023-2024 | |
| Mylan Specialty L.P. | $137.22 | 2022-2023 | Yupelri |
| Allergan, INC. | $118.24 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $111.39 | 2019-2020 | |
| Amgen INC. | $84.98 | 2019-2022 | |
| Genzyme Corporation | $75.90 | 2019 | |
| Axsome Therapeutics, INC. | $59.71 | 2023 | Sunosi |
| Abbvie INC. | $45.84 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $27.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $25.01 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $23.39 | 2021 | |
| Novo Nordisk INC | $20.69 | 2023 | Ozempic |
| Inspire Medical Systems, INC. | $18.39 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $15.97 | 2024 | Ojjaara |
| Tanabe Pharma America, INC. | $15.94 | 2020 | |
| Lilly USA, LLC | $15.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.